{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:05:12Z","timestamp":1779138312390,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.preghy.2025.101232","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:09:34Z","timestamp":1750806574000},"page":"101232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Peripartum antihypertensive use and the risk of neonatal hypoglycemia and postpartum uterine atony: a retrospective cohort study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-1357","authenticated-orcid":false,"given":"Amnon A.","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0283-3772","authenticated-orcid":false,"given":"Samantha L.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2157-7607","authenticated-orcid":false,"given":"Alina","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-5241","authenticated-orcid":false,"given":"Yunping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-0102","authenticated-orcid":false,"given":"Philip E.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2025.101232_b0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011\u20132013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101232_b0010","doi-asserted-by":"crossref","unstructured":"Y.H. Neggers, Trends in maternal mortality in the United States. Reprod. Toxicol. Elsevier Inc.; 2016;64:72\u20136.","DOI":"10.1016\/j.reprotox.2016.04.001"},{"key":"10.1016\/j.preghy.2025.101232_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0163-7258(83)90060-8","article-title":"Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions","volume":"21","author":"Kendall","year":"1983","journal-title":"Pharmacol. Ther. Pergamon."},{"key":"10.1016\/j.preghy.2025.101232_b0020","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2214-109X(15)00214-4","article-title":"Nifedipine for tocolysis","volume":"4","author":"Stones","year":"2016","journal-title":"Lancet Glob. Heal."},{"key":"10.1016\/j.preghy.2025.101232_b0025","doi-asserted-by":"crossref","first-page":"134.e1","DOI":"10.1016\/j.ajog.2010.11.038","article-title":"Nifedipine in the management of preterm labor: a systematic review and metaanalysis","volume":"204","author":"Conde-Agudelo","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101232_b0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tjog.2015.07.005","article-title":"Progesterone and nifedipine for maintenance tocolysis after arrested preterm labor: a systematic review and meta-analysis of randomized controlled trial","volume":"55","author":"Ding","year":"2016","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101232_b0035","article-title":"Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia","volume":"138","author":"Bateman","year":"2016","journal-title":"Pediatrics. Am. Acad. Pediat."},{"key":"10.1016\/j.preghy.2025.101232_b0040","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1080\/14767058.2019.1651270","article-title":"Distinct outcomes of labetalol exposed infants: case reports and systematic review","volume":"34","author":"Yang","year":"2021","journal-title":"J. Matern. Neonatal. Med."},{"key":"10.1016\/j.preghy.2025.101232_b0045","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/1471-0528.12428","article-title":"Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study","volume":"120","author":"Bateman","year":"2013","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2025.101232_b0050","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med. Public Libr. Sci."},{"key":"10.1016\/j.preghy.2025.101232_b0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2019.01.022","article-title":"IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy\u2013a randomized controlled trial","volume":"236","author":"Zulfeen","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2025.101232_b0060","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.3390\/ijerph19159616","article-title":"The risk for neonatal hypoglycemia and bradycardia after beta-blocker use during pregnancy or lactation a systematic review and meta-analysis","volume":"19","author":"de Bruin","year":"2022","journal-title":"Int. J. Environ. Res. Public Health. NLM (Medline)"},{"key":"10.1016\/j.preghy.2025.101232_b0065","first-page":"724","article-title":"Short-term neonatal outcome among term infants after in-utero exposure to beta blockers","volume":"21","author":"Mazkereth","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.preghy.2025.101232_b0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.earlhumdev.2011.12.012","article-title":"Neonatal side effects of maternal labetalol treatment in severe preeclampsia","volume":"88","author":"Heida","year":"2012","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.preghy.2025.101232_b0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/HJH.0000000000002256","article-title":"Neonatal effects of intrauterine metoprolol\/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups","volume":"38","author":"Kayser","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.preghy.2025.101232_b0080","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/14767058.2016.1193145","article-title":"Neonatal haemodynamic effects following foetal exposure to labetalol in hypertensive disorders of pregnancy","volume":"30","author":"Thewissen","year":"2017","journal-title":"J. Matern. Neonatal Med."},{"key":"10.1016\/j.preghy.2025.101232_b0085","doi-asserted-by":"crossref","unstructured":"A. Tyagi, A. Mohan, Y. Singh, A. Luthra, D. Garg, R.K. Malhotra, Effective dose of prophylactic oxytocin infusion during cesarean delivery in 90% population of nonlaboring patients with preeclampsia receiving magnesium sulfate therapy and normotensives: an up-down sequential allocation dose-response study. Anesth. Analg. 2021;Publish Ah:303\u201311.","DOI":"10.1213\/ANE.0000000000005701"},{"key":"10.1016\/j.preghy.2025.101232_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0037-1613675","article-title":"Clinical experience with the implementation of accurate measurement of blood loss during cesarean delivery: influences on hemorrhage recognition and allogeneic transfusion","volume":"35","author":"Rubenstein","year":"2018","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.preghy.2025.101232_b0095","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1213\/01.ane.0000286233.48111.d8","article-title":"The accuracy of blood loss estimation after simulated vaginal delivery","volume":"105","author":"Toledo","year":"2007","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.preghy.2025.101232_b0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1479-828X.1996.tb03273.x","article-title":"A comparison between visual estimation and laboratory determination of blood loss during the third stage of labour","volume":"36","author":"Razvi","year":"1996","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2025.101232_b0105","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS randomized controlled trial (control of hypertension in pregnancy study)","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101232_b0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/AOG.0000000000005410","article-title":"Perinatal outcomes associated with management of stage 1 hypertension","volume":"142","author":"Bailey","year":"2023","journal-title":"Obstet. Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:12Z","timestamp":1778840892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925000480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S2210778925000480"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101232","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripartum antihypertensive use and the risk of neonatal hypoglycemia and postpartum uterine atony: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101232"}}